Introduction {#Sec1}
============

*In silico* drug discovery is an important task because experimental identification and verification of therapeutic compounds are time-consuming and expensive processes. There are two major trends in *in silico* drug discovery: the ligand-based approach^[@CR1]^ and structure-based approach^[@CR2]^. The former is straightforward: new drug candidates are identified based upon the similarity with known drugs no matter how the similarity is evaluated. Although it is a powerful method, there are some drawbacks: if there are no known drugs for target proteins, then there is no way to find new drug candidates. Even if there are many known drugs for the target protein, it is hopeless to try to find compounds that are effective but without any similarity to known drugs. The second, structure-based approach, can address these weaknesses. It can identify new therapeutic compounds even without the information about known drugs. Of course, there are some drawbacks in this strategy too. If the target protein's structure is not known, it must be predicted prior to the drug discovery process. Even if the target protein's structure is known, because we need to numerically verify the binding affinity between the ligand compound and target protein -- this work also requires a large amount of computational resources -- structure-based *in silico* drug discovery is still far from easy to implement. In addition, the accuracy of prediction of protein structure and of ligand-binding structure is not very high^[@CR3]^. Thus, it would be helpful to have an additional or alternative strategy for *in silico* drug discovery.

Recently, an alternative approach was proposed that is aimed at finding drug candidates computationally using gene expression profiles of cell lines treated with compounds^[@CR4],[@CR5]^. This third approach is not straightforward. Firstly, because compounds target not mRNAs but proteins, mRNA expression of drug target proteins is not always affected. Therefore, direct identification of a drug target protein in gene expression data cannot be done. Secondly, gene expression alteration caused by treatment with a compound may be context dependent; in other words, in a cell line, the gene expression change caused by incubation with a compound may differ from that in diseases. To compensate for these difficulties, the gene expression signature strategy was developed^[@CR6],[@CR7]^. In this approach, gene expression alteration profiles caused by treatment of a cell line with various drug candidates are compared with those of known drugs. If the profiles are similar, then new drug candidates are expected to function similarly to known drugs. Although this third strategy is useful, if there are no known drugs for the disease under study, then this approach cannot function, as in the case of ligand-based methods. In this paper, I propose a strategy that can infer drug candidates from profiles of drug treatment-associated gene expression without the information about known compounds for diseases. In this strategy, I employ the tensor decomposition (TD)-based unsupervised feature extraction (FE) approach, which is an extension of the recently proposed principal component analysis (PCA)-based unsupervised FE; PCA-based unsupervised FE has successfully solved various bioinformatic problems^[@CR8]--[@CR28]^. PCA-based unsupervised FE has also been often applied to integrated analysis. In their integrated approach, after PCA-based unsupervised FE is applied to an individual dataset separately, genes are selected from each of these datasets. Then, intersections among them are evaluated as gene sets carrying greater confidence. This strategy has been applied to the identification of genes associated with aberrant promoter methylation common among three autoimmune diseases^[@CR14]^, identification of genes commonly affected by two histone deacetylase inhibitors^[@CR11]^, and identification of reliable biomarkers considering microRNA, mRNA expression, and compounds together^[@CR20]^. The advantage of these integrated analyses using PCA-based unsupervised FE compared with standard integrated analysis is that there is no need for a weight factor, which is necessary to integrate multiple datasets because PCA-based unsupervised FE was applied to an individual dataset separately. On the other hand, this strategy, i.e. integrated analysis by applying PCA-based unsupervised FE to an individual dataset separately also has some drawbacks: when there are no common gene sets, there is no way to proceed with the analysis although there are rarely no common gene sets. To compensate for this weakness without introducing weights, in the newly developed TD-based strategy here, tensors are generated using a mathematical product of a gene expression profile of drug-treated cell lines and of a gene expression profile of a disease. This approach does not require any weights that a linear combination inevitably requires. Then, pairs of compounds and genes are identified, where the gene's mRNA expression alteration is associated with drug-treated cell lines and is simultaneously coincident with such an alteration during disease progression. Drug target genes are further inferred based upon gene expression profiles when single-gene knockout or overexpression experiments are conducted. In this study, the inferred gene--compound interactions were found to significantly overlap with known gene--compound interactions.

Results {#Sec2}
=======

TD-based unsupervised FE is applied to a combined tensor {#Sec3}
--------------------------------------------------------

In this study, to demonstrate the usefulness of the present strategy even when applied to various diseases, I consider application to multiple diseases as follows. In the text that follows, I describe detailed results for all the diseases analysed in this study. For a summary of this section, see Table [1](#Tab1){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"} Table 1A summary of TDs and identification of various singular value vectors for identification of candidate drugs and genes used to find genes encoding drug target proteins.diseasestensorscore tensorsingular value vectorsDrugMatrixdiseasegeneratedheart failure$\documentclass[12pt]{minimal}
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Combined analysis of human diseases and rat tissues {#Sec4}
---------------------------------------------------

Here, I focused on multiple human diseases and rat tissues for the following reason. If the proposed strategy is tested on only a single combination of human diseases and rat tissues, then the probability of success is rather low. Therefore, it is better to test the strategy on as many combinations as possible. On the other hand, if the number of compounds tested on some rat tissue is not large enough, then this tissue is not suitable for the present study because the purpose of this study is to apply TD-based unsupervised FE to drug discovery; a smaller number of tested compounds means fewer opportunities for identification of an effective drug. Using this criterion, I selected five tissues, i.e. heart, brain, born narrow, kidney, and liver tissues, on which 22--315 drugs have been tested.

Next, I selected diseases with which the five tissues are analysed together. During this selection, diseases that are supposed to take place in the corresponding tissues should be chosen; otherwise, correct drug selection is unlikely. For heart tissue, I used heart failure. For brain tissue, I used post-traumatic stress disorder (PTSD). For bone narrow tissue, I selected acute lymphocytic leukaemia (ALL). For kidney tissue, I used diabetes and cancer. For liver tissue, I chose cirrhosis. The reason why I used two diseases with kidney tissue is to check whether distinct genes are identified for different diseases when I use distinct gene expression profiles.

Heart failure {#Sec5}
-------------

In gene expression profiles of the rat left ventricle (LV) treated with 218 drugs, I selected four time points (1/4, 1, 3, and 5 days after treatment); this is because there were substantially smaller numbers of compounds tested for other time points than for these four. On the other hand, human heart gene expression profiles represent 82 patients with idiopathic dilated cardiomyopathy, 95 patients with ischemic stroke, and 136 healthy controls. In these profiles, 3937 genes sharing gene symbols between humans and rats were considered. Then the generated tensor is$$\documentclass[12pt]{minimal}
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We also need to know which sample singular value vectors generated from gene expression of disease samples are associated with the difference between healthy controls and diseases. These data must be evaluated on a case-to-case basis because gene expression profiles of disease samples do not have any unified format.
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PTSD {#Sec6}
----

In gene expression profiles of the rat brain treated with 22 drugs, I selected four time points (1/4, 1, 3, and 5 days after treatment); this is because there were substantially smaller numbers of compounds tested for other time points. Rat hippocampus and amygdala gene expression profiles of 15 males and 15 females are composed of five control samples, five minimal behavioural response samples, and five extreme behavioural response samples, respectively. In these profiles, 7501 genes sharing gene symbols between the two experiments were considered. Then, the generated tensor is$$\documentclass[12pt]{minimal}
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In relation to the rat model of PTSD, the set of samples is composed of 30 female and male samples, and each of these groups represents 15 hippocampus samples and 15 amygdala samples. Fifteen rats were subdivided into five controls, five minimal-behavioural-response samples, and five extreme-behavioural-response ones. Figure [3B](#Fig3){ref-type="fig"} shows the comparisons of sample singular value vectors $\documentclass[12pt]{minimal}
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ALL {#Sec7}
---

From gene expression profiles of the rat bone narrow treated with 77 drugs, I selected four time points (1/4, 1, 3, and 5 days after treatment); this is because there were substantially smaller numbers of compounds tested for other time points than for these four. On the other hand, gene expression profiles of bone narrow in human (child) ALL represents 74 ALL patients at 0, 8, 15, and 33 days after a remission induction therapy. In these profiles, 2597 genes sharing gene symbols between rats and humans were considered. Then, the generated tensor is$$\documentclass[12pt]{minimal}
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Regarding ALL, in contrast to the other diseases, the given samples represent not diseases and controls but rather time progression of gene expression after therapy. Then, because the fourth singular value vector of time points (Fig. [3C](#Fig3){ref-type="fig"}), $\documentclass[12pt]{minimal}
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Diabetes {#Sec8}
--------

In gene expression profiles of the rat kidney treated with 253 drugs, I selected four time points (1/4, 1, 3, and 5 days after treatment); this is because there were substantially smaller numbers of compounds tested for other time points than for these four. Kidney gene expression of 50 controls (25 whole kidneys, 12 tubuli, and 13 glomeruli) and 19 diabetic kidney samples were considered. In these data, 3489 genes sharing gene symbols between rats and humans were analysed. Then the generated tensor is$$\documentclass[12pt]{minimal}
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Renal carcinoma {#Sec9}
---------------

Rat kidney samples were also combined with human renal carcinoma samples, which represent 101 human patients (one tumour sample and one sample of adjacent non-tumourous renal tissue from each patient) because some correlation between diabetes and renal carcinoma has been reported^[@CR29]^. If the present strategy works similarly for both diseases, then these results can strengthen its usefulness. Among genes included in rat kidney and renal carcinoma profiles, 4036 genes sharing gene symbols between rats and humans were considered. Accordingly, the generated tensor is$$\documentclass[12pt]{minimal}
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Prior to selection of genes and compounds, we need to know which singular value vector of time points, $\documentclass[12pt]{minimal}
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Regarding renal carcinoma, the samples represent 101 patients, from whom one tumorous and one healthy tissue sample were taken. In this case, the first several singular value vectors do not show a significant difference between healthy and tumorous tissue samples. Thus, I performed BH corrections on all the *P*-values attributed to 202 singular value vectors of samples, $\documentclass[12pt]{minimal}
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                \begin{document}$${\ell }_{3}=\mathrm{13,}\,\mathrm{15,}\,\mathrm{30,}\,\mathrm{33,}\,35$$\end{document}$ (Fig. [3E](#Fig3){ref-type="fig"}), can be used to find singular value vectors of genes and drugs for identification of genes and drugs in the analysis below.
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                \begin{document}$${\ell }_{4}=\mathrm{186,}\,\mathrm{215,}\,\mathrm{233,}\,\mathrm{244,}\,\mathrm{251,}\,\mathrm{269,}\,\mathrm{274,}\,\mathrm{309,}\,\mathrm{312,}\,318$$\end{document}$ were selected, which are used for identification of genes with altered expression. Genes encoding drug target proteins are later inferred by the enrichment analysis of these genes regarding the genes associated with altered gene expression when genes encoding drug target proteins are perturbed.

Cirrhosis {#Sec10}
---------

In gene expression profiles of the rat liver treated with 355 drugs, I selected four time points (1/4, 1, 3, and 5 days after treatment); this is because there were substantially smaller numbers of compounds tested for other time points. Human liver gene expression profiles of patients with cirrhosis are composed of 216 samples (60 correspond to a good prognosis, 101 to an intermediate prognosis, and 55 samples correspond to a poor prognosis). In these profiles, 3961 genes sharing gene symbols between rats and humans were considered. Then the generated tensor is$$\documentclass[12pt]{minimal}
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                \begin{document}$${u}_{{\ell }_{4}i}\in {{\mathbb{R}}}^{3961\times 3961}$$\end{document}$ were obtained.

Prior to selection of genes and compounds, we need to know which singular value vector of time points, $\documentclass[12pt]{minimal}
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                \begin{document}$${u}_{{\ell }_{2}{j}_{2}}$$\end{document}$, represents time dependence (Fig. [2](#Fig2){ref-type="fig"}). Then, I decided to use the second singular value vectors ($\documentclass[12pt]{minimal}
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                \begin{document}$${\ell }_{2}=2$$\end{document}$) for cirrhosis.

As for cirrhosis, the second and sixth singular value vectors of samples, $\documentclass[12pt]{minimal}
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                \begin{document}$${u}_{{\ell }_{3}\in \mathrm{(2,6),}{j}_{3}}$$\end{document}$, show gradual and significant dependence on progression of diseases (Fig. [3F](#Fig3){ref-type="fig"}), from good to intermediate to poor prognosis. Accordingly, I decided to use these two. Because analysis of the sixth may be a bad approach, I performed BH criterion corrections on *P*-vales and confirmed that these two vectors are still significant.
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                \begin{document}$$2\le {\ell }_{4}\le 10$$\end{document}$ were selected, which are used for identification of genes with altered expression. Genes encoding drug target proteins are later inferred by the enrichment analysis of these genes regarding the genes associated with altered gene expression when genes encoding drug target proteins are perturbed.

Identification of drugs and drug target proteins {#Sec11}
------------------------------------------------

By means of gene and compound singular value vectors $\documentclass[12pt]{minimal}
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                \begin{document}$${u}_{{\ell }_{1},{j}_{1}}$$\end{document}$, which were selected in the previous subsections and are listed in Table [1](#Tab1){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"}, drug candidates and genes encoding drug target proteins were identified as suggested in Fig. [4](#Fig4){ref-type="fig"}

Firstly, I considered candidate drugs (for the full list, see Table [S2](#MOESM3){ref-type="media"}). Except for ALL, the second singular value vector of compounds, $\documentclass[12pt]{minimal}
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                \begin{document}$${u}_{{\ell }_{1}\mathrm{=2,}{j}_{1}}$$\end{document}$, was identified. Thus, I decided to select outliers with it (Fig. [5](#Fig5){ref-type="fig"}). In the previous applications where PCA was used for identification of genes, I employed *P*-values attributed to each gene, assuming a *χ* ^2^ distribution. Unfortunately, this strategy could not be applied to the identification of candidate drugs. When trying to identify critical genes, I also observed gene expression of other, non-critical genes. Consequently, I could identify critical genes using comparisons with them. As for the drugs, however, drugs that are unlikely to affect the rat tissues being considered were not tested. Thus, in a sense, all the analysed drugs are seemingly critical. Therefore, I decided to identify drugs belonging to the cluster farthest from the origin. Because the definition of a cluster may be arbitrary, the selection of genes may not be unique (more detailed criteria and the list of selected drugs are presented in supplementary materials, Text [S1](#MOESM1){ref-type="media"}).Figure 5A histogram of the second singular value vectors of compounds. Red parts represent drugs selected as outliers, and vertical blue dashed lines are origins of the axes, by the distances from which the outliers were identified.

Regarding identification of genes encoding drug target proteins, I utilised the following strategy as suggested in Fig. [4](#Fig4){ref-type="fig"}. Firstly, genes were selected using *P*-values computed from gene singular value vectors listed in Table [1](#Tab1){ref-type="table"} (*P*-values were calculated assuming *χ* ^2^ distributions for gene singular value vectors; genes associated with *P*-values adjusted by the BH criterion and less than 0.01 were selected; for the full list, see Table [S2](#MOESM3){ref-type="media"}). Then, these genes were uploaded to Enrichr^[@CR30]^ to identify genes encoding drug target proteins via 'Single Gene Perturbations from GEO up' and 'Single Gene Perturbations from GEO down' categories. After that, genes associated with adjusted *P*-values less than 0.01 were selected as genes encoding drug target proteins (Supporting Data [S1](#MOESM4){ref-type="media"}).

Biological evaluation of the selected compounds and genes {#Sec12}
---------------------------------------------------------

At first, it was tested whether known drug target proteins were enriched among those identified by the present strategy. To obtain the list of known drug target proteins, I used DINIES^[@CR31]^. Although it can also infer unknown interactions between drugs and proteins, by uploading a single drug using a DINIES search with parameters 'chemogenomic approach' and 'with learning on all DBs', I obtained the list of target proteins of individual drugs (Supporting Data [S2](#MOESM5){ref-type="media"}). Next, target genes were collected for individual drugs, and the collected sets of target genes were generated and used for further analysis in the text below.

To evaluate significant overlaps between the set of target genes predicted by DINIES and those with gene expression profiles, I carried out Fisher's exact test and the uncorrected *χ* ^2^ test (Table [2](#Tab2){ref-type="table"}). After that, I found that most of cases (10 out of 12 tables) are associated with significant *P*-values (Δ*G* Table 2Fisher's exact test (*P* ~*F*~) and the uncorrected *χ* ^2^ test (*P* ~*χ*~ ^2^) of known drug target proteins regarding the inference of the present study.Single Gene Perturbations from GEO upSingle Gene Perturbations from GEO downFT*P* ~*F*~*P* ~χ~ ^2^ROFT*P* ~*F*~*P* ~*χ*~ ^2^ROheart failureF5215173.4 × 10^−4^3.9 × 10^−4^3.026284161.3 × 10^−3^7.3 × 10^−4^2.61T13391933PTSDF5005603.8 × 10^−2^3.1 × 10^−2^2.675325296.1 × 10^−3^4.5 × 10^−3^3.81T618519ALLF979892.7 × 10^−1^3.0 × 10^−1^2.191009571.0 × 10^0^------T102120diabetesF8891771.2 × 10^−2^7.1 × 10^−3^3.009361303.6 × 10^−4^2.0 × 10^−5^5.13T1591410renal carcinomaF8472192.0 × 10^−2^1.2 × 10^−2^2.758951694.3 × 10^−2^2.2 × 10^−2^2.64T1410168cirrhosisF5722191.1 × 10^−2^8.1 × 10^−3^2.915951691.6 × 10^−3^1.1 × 10^−3^3.81T81078Rows: known drug target proteins (DINIES). Columns: Inferred drug target proteins using 'Single Gene Perturbations from GEO up' or 'Single Gene Perturbations from GEO down'. OR: odds ratio.) for both tests. Odds ratios are also generally approximately equal to three, which is usually considered large enough. Therefore, the proposed strategy improves identification of drug target proteins three-fold over random selection; this enhancement is large enough for effectiveness. Thus, it is obvious that this strategy is successful.

One may wonder whether Table [2](#Tab2){ref-type="table"} supports the usefulness of the present strategy because, generally, most genes identified as drug target genes by the present strategy are false positives although the inference and previous knowledge are significantly related. In this case, however, the situation is a little bit different from usual cases. For example, proteins inferred in the present study but not supported by previous knowledge may simply reflect the lack of experiments. In this case, these apparent false positives may turn out to be a true positive after suitable experimental validation. Alternatively, proteins supported by previous knowledge but not by the present study (i.e. false negatives) may simply reflect the lack of perturbation experiments. Proteins not included in perturbation experiments cannot be listed as true positives in the present study. This means that more perturbation experiments and additional validation of protein--drug interactions should be performed to validate the present results more precisely.

Readers may also wonder whether this kind of identification is useful because we are dealing with many-to-many correspondence not one-to-one correspondence. Nevertheless, target gene identification by DINIES was largely found to overlap among multiple compounds. As shown in Fig. [6](#Fig6){ref-type="fig"}, a substantial proportion of genes was targeted by more than a single compound, except for ALL where only two compounds were selected. In this sense, the proposed strategy successfully identifies a set of genes that share, to some extent, the compounds targeting these genes.Figure 6A histogram of the number of genes targeted by multiple compounds according to the results obtained after the identified drugs were uploaded to the DINIES server.

Discussion {#Sec13}
==========

A question may arise whether the present study can be useful for real drug discovery experiments because there are more than a hundred genes listed for individual diseases (Table [2](#Tab2){ref-type="table"}). To demonstrate the usefulness of the proposed strategy, in the text below, I specifically consider two genes, *CYPOR* and *HNF4A*, listed at the top for cirrhosis; CYPOR is top-ranked according to 'Single Gene Perturbations from GEO up', whereas HNF4A is top-ranked based on 'Single Gene Perturbations from GEO down'. At present, there are no drugs directly targeting cirrhosis; thus, the strategy will hold some promise if we can propose some candidate drugs based on this analysis.

Although the CYPOR protein has never been specifically studied in relation to cirrhosis, the activity of cytochrome P450 enzymes, to which CYPOR belongs, is regarded as important in this disease^[@CR32]^. Accordingly, CYPOR may be an important therapeutic target in cirrhosis. Although no ligand compounds are known for CYPOR, bezafibrate was evaluated as a candidate ligand by *in silico* analysis (Fig. [7A](#Fig7){ref-type="fig"}). Its estimated binding energy, Δ*G*, is equal to 9.73 kcal, which corresponds to *K* ~*i*~ = *exp*(−(Δ*G*)/(*RT*)) = 79 nM (*T* = 300 K), which is small enough to consider bezafibrate a useful ligand (*R* = 8.31 is the gas constant). Because bezafibrate itself is a known CYP inhibitor^[@CR33]^, it is plausible that bezafibrate can be a drug for cirrhosis because of effects on CYPOR.Figure 7(**A**) Binding structure of bezafibrate toward CYPOR computed by SwissDock. (**B**) Binding structure of bezafibrate toward the ligand-binding domain of HNF4A computed by SwissDock. (**C**) Binding structure of morphine toward CYPOR computed by SwissDock. (**D**) Binding structure of morphine toward the ligand-binding domain of HNF4A computed by SwissDock.

Although HNF4A has long been an orphan receptor, a ligand was identified recently^[@CR34]^. Among the compounds identified by the present strategy, bezafibrate was estimated to bind to the ligand-binding domain of HNF4A with high affinity (Δ*G* = 9.44 kcal, which corresponds to 0.13 *μ*M at *T* = 300 K) by *in silico* analysis (Fig. [7B](#Fig7){ref-type="fig"}). Given that the structure of the ligand-binding domain is supposed to affect that of the DNA-binding domain^[@CR35]^ (even can enhance the binding), and HNF4A is a transcription factor that can affect cirrhosis^[@CR36]^, bezafibrate may also be a drug for cirrhosis from this point of view.

Although this is only one example and is limited to *in silico* analysis, if also considering that some researchers reported the efficiency of bezafibrate toward cirrhosis^[@CR37],[@CR38]^, it indicates that the findings here can be a starting point for identification of new candidate drugs for diseases.

To evaluate the validity of this *in silico* analysis, I tried to assess binding of a possible negative control, morphine, which is unlikely to bind to either CYPOR or HNF4A (Fig. [7C and D](#Fig7){ref-type="fig"}). Morphine turned out to have relatively weak binding affinities (Δ*G* = 8.14 and 8.08 kcal, respectively, both of which correspond to 1.3 *μ*M). This result suggested that our strategy successfully identified drugs that can bind to target proteins with relatively strong binding affinity.

One may wonder whether only ten fold difference (0.13 *μ*M for bezafibrate vs 13 *μ*M for morphine) is significant enough or not. Nonetheless, these values should be evaluated not as the absolute values, but as the relative binding affinity towards proteins. In order to access the general binding affinity towards proteins, I accessed ChEMBL^[@CR39]^ that stores vast number of experimentally validated compounds-protein interactions. Then I have found three records for morphine (CHEMBL409938), 0.32 nM with MOP, 11 nM with OPRD1, and 230 nM with OPRK1. On the other hand, I have found two records for bezafibrate (CHEMBL264374), 33 *μ*M for FABP2 and 44 *μ*M for FABP1. Thus, the best record of morphine in ChEMBL is more than 10^5^ times better than that of bezafibrate. Thus, our finding that bezafibrate is ten times better than morphine is definitely remarkable.

Finally, I would like to comment on the related studies. To my knowledge, there are no existing unsupervised methods comparable to the proposed one. The reason is as follows. To perform analyses similar to the present one, in a sense, multi-view data analyses^[@CR40]^ are necessary, because two independent datasets, i.e. DrugMatrix and disease gene expression profiles, must be integrated. There are no existing unsupervised multi-view analytical methods by which more than one feature selection can be performed. For instance, Khan *et al*.^[@CR41]^ proposed multi-tensor decomposition (thus, by definition, an unsupervised method) and applied it to drug discovery; they could identify only compounds and could not identify any drug target genes because by means of their methodology, only features shared across multiple views (in their case compounds) can be screened. Although Li^[@CR42]^ proposed an integrated method that can identify drug--target protein interactions, the method is fully supervised because it cannot identify new drug--target protein interactions without any pre-knowledge.

Before closing the discussion, I would like to comment on the rationality of the present strategy. It is not obvious that applying TD to a mathematical product to obtain singular value vectors is guaranteed success because the relation between the mathematical product and the obtained singular value vectors is unclear. Nevertheless, the same problem had already existed when PCA was applied to gene expression. PCA is essentially matrix factorisation that approximates a matrix as a matrix product. This means that dimensionality of the resulting matrices can never be the same as that of the original gene expression matrix. As readers can see in eq. (([7](#Equ7){ref-type=""})), the order of the products of singular value vectors is the same as the order of modes which can take any values. In this sense, dimensionality of the original matrix and that of the obtained matrix after application of TD to the original matrix can never match each other. Any kinds of matrix factorisation or TD simply represent assumptions that may become good approximations. If they work (in the present study, this word indicates that the resulting singular value vectors can be biologically interpretable), this means that the assumption is suitable. If not, it is not reliable. In this study, applying TD to a mathematical product clearly worked well, i.e. the obtained singular value vectors are biologically interpretable. Therefore, the proposed strategy is suitable for the present study and for the dataset being analysed, nothing more. I also would like to emphasize that the present strategy cannot fully replace the compounds or structure based approach that can screen huge number of compounds as many as millions. Until there are more gene expression profiles available, the present strategy must be regarded as only a supportive methodology toward these two main stream strategies.

Methods {#Sec14}
=======

Mathematics of TD {#Sec15}
-----------------

In this subsection, I briefly discuss what TD is and how I apply it to the problem at hand. Suppose an *m*-mode tensor, *X*, whose components are denoted as $\documentclass[12pt]{minimal}
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                \begin{document}$${x}_{{j}_{1},\ldots ,{j}_{m-1}i}\in {{\mathbb{R}}}^{{N}_{1}\times {N}_{2}\times \cdots \times {N}_{m}}$$\end{document}$, represents expression of the *i* th gene under the *j* ~*k*~ (*k* = 1, ..., *m* − 1, *j* ~*k*~ = 1, ..., *N* ~*k*~) conditions, examples of which are diseases, patients, tissues, and time points. Then, TD is defined as$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
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                \begin{document}$$G({\ell }_{1},\ldots ,{\ell }_{m})\in {{\mathbb{R}}}^{{N}_{1}\times {N}_{2}\times \cdots \times {N}_{m}}$$\end{document}$ is a core tensor and $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
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The advantages over more popular TD -- parallel factor analysis (PARAFAC)^[@CR43]^ -- are as follows. First of all, PARAFAC is NP-complete; in other words, there are no known algorithms that derive PARAFAC with polynomial time. Especially, in the present analysis, singular value vectors associated with a smaller contribution were often useful; $\documentclass[12pt]{minimal}
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                \begin{document}$${\ell }_{k}$$\end{document}$. By contrast, as shown in Table [1](#Tab1){ref-type="table"}, the observed correspondence between singular value vectors is not one to one but often many to many, in which case, HOSVD was more suitable. For these two reasons, I decided to conduct HOSVD instead of more popular PARAFAC.

Tensor generation for integrated analysis {#Sec16}
-----------------------------------------

Often, there is a set of gene expression profiles of human cell lines or model animals treated with various compounds at multiple dose densities. DrugMatrix^[@CR44]^ and LINCS^[@CR45]^ are good examples although the former comprises only temporal gene expression after treatment with various drugs. Nonetheless, it is not easy to infer a drug's action on diseases by means of only these gene expression profiles. Some kind of integrated analysis with disease gene expression profiles is necessary, but it is not so straightforward. Candidate drugs should satisfy these conditions:Gene expression in these profiles must significantly decrease or increase with the increasing dose density of a compound.Gene expression alteration caused by drug treatment must be significantly coincident with that associated with disease progression.

How these two independent significance values can be evaluated is unclear. For example, we can have two sets of significant gene expression alterations of the *i* th gene, {Δ*x* ~*i*~}, caused by drug treatment and those of the *i*′ th gene, {Δ*x*′~*i*′~}, during disease progression, respectively. Firstly, we need to test whether the two sets of genes significantly overlap. Next, when there is a significant overlap, we have to determine whether these two gene expression alteration profiles correlate significantly. Furthermore, because the analysis is usually conducted among multiple compounds, all the significance evaluation must be corrected based upon a multiple-comparison criterion. This is obviously a complicated and unpromising strategy.

On the other hand, if we can have gene expression profiles expressed via a tensor, *x* *j* ~1~...j~m~ ~−~ ~1~i, where *j* ~*k*~, *k* = 1, ..., *m* − 1 corresponds to drug candidates, dose density, and disease progression, we can easily evaluate a candidate drug using TD: eq. (([7](#Equ7){ref-type=""})). If there are $\documentclass[12pt]{minimal}
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                \begin{document}$${\sigma }_{{\ell }_{k}}$$\end{document}$ are standard deviations. After adjustment of *P*-values via the BH criterion^[@CR46]^, genes and compounds that have significant *P*-values, i.e. less than 0.01, are selected as those contributing to the specified singular value vectors. Nonetheless, because such a tensor can be obtained only when drug treatment is performed on patients, this strategy is useless; if we can test drug efficiency directly on patients, then there is no need for *in silico* drug discovery. To overcome this obstacle, I replace *x* *j* ~1~...j~m~ ~−~ ~1~i with a 'mathematical product'; hereafter, this means that each component is defined as a product of two components, i.e.$$\documentclass[12pt]{minimal}
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                \begin{document}$${x}_{{j}_{1}\ldots {j}_{m \textquotedbl }i}\in {{\mathbb{R}}}^{{N}_{1}\times \cdots \times {N}_{m \textquotedbl }}$$\end{document}$ is gene expression for the patients (*m* − 1 = *m*′ + *m*″). Because these two datasets can be obtained independently, we can test any kind of combinations of drug treatments and diseases even after all measurements were finalised. It is also obvious that this strategy retains the advantages of integrated analysis using PCA-based unsupervised FE because it still does not require assignment of any weights to each gene's expression. On the other hand, it compensates the shortcoming of the integrated analysis of PCA-based unsupervised FE. Because this strategy identifies genes by considering expression of two genes in an integrated manner, there is no need to use common sets among multiple genes selected within an individual dataset as in the PCA based unsupervised FE.

Explanation of the present strategy {#Sec17}
-----------------------------------

Here is an accessible description of the present strategy (Fig. [4](#Fig4){ref-type="fig"}). It is obvious that the success of this seemingly complicated method heavily depends upon whether I can easily (or usually, in other words) obtain such preferable combinations of singular value vectors that have the properties illustrated in Fig. [4](#Fig4){ref-type="fig"}. Although this situation is unlikely to happen often, it seems to be possible in many cases as shown in the text above.

Gene expression profiles {#Sec18}
------------------------

### Heart failure {#Sec19}

Gene expression profiles of the heart for drug treatments of rats were retrieved from DrugMatrix under the gene expression omnibus (GEO) ID GSE59905, whereas human gene expression for heart failure was retrieved from GEO ID 57345. For both datasets, expression files of genes GSE57345-GPL11532_series_matrix.txt.gz, GSE59905-GPL5426_series_matrix.txt.gz, and GSE59905-GPL5425_series_matrix.txt.gz were directly downloaded from the series matrix.

### The rat model of PTSD {#Sec20}

Gene expression profiles of the brain for drug treatments of rats were retrieved from DrugMatrix under GEO ID GSE59895, whereas amygdala and hippocampus gene expression for the rat model of PTSD was taken from GEO ID GSE60304. For both datasets, expression files of genes GSE60304_series_matrix.txt.gz, GSE59895-GPL5425_series_matrix.txt.gz, and GSE59895-GPL5426_series_matrix.txt.gz were directly downloaded from the series matrix.

### ALL {#Sec21}

Gene expression profiles of bone marrow for drug treatments of rats were retrieved from DrugMatrix under GEO ID GSE59894, and ALL human bone marrow gene expression was taken from GEO ID GSE67684. For both datasets, expression files of genes GSE67684-GPL570_series_matrix.txt.gz, GSE67684-GPL96_series_matrix.txt.gz, GSE59894-GPL5425_series_matrix.txt.gz, and GSE59894-GPL5426_series_matrix.txt.gz were directly downloaded from the series matrix.

### Diabetes and renal cancer {#Sec22}

Gene expression profiles of kidneys for drug treatments of rats were retrieved from DrugMatrix under GEO ID GSE59913, whereas gene expression for diabetic human kidneys and renal cancer was obtained from GEO ID GSE30122 and GSE40435, respectively. For these datasets, expression files of genes GSE30122_series_matrix.txt.gz, GSE40435_series_matrix.txt.gz, GSE59913-GPL5424_series_matrix.txt.gz, GSE59913-GPL5425_series_matrix.txt.gz, and GSE59913-GPL5426_series_matrix.txt.gz were directly downloaded from the series matrix.

### Cirrhosis {#Sec23}

Gene expression profiles of the liver for drug treatments of rats were retrieved from DrugMatrix under GEO ID GSE59923, whereas gene expression for cirrhosis of the human liver was obtained from GEO ID GSE15654. For both datasets, GSE15654_series_matrix.txt.gz, GSE59923-GPL5424_series_matrix.txt.gz, GSE59923-GPL5425_series_matrix.txt.gz, and GSE59923-GPL5426_series_matrix.txt.gz were directly downloaded from the series matrix.

An enrichment analysis server {#Sec24}
-----------------------------

Gene symbols were uploaded to Enrichr^[@CR30]^. Then, 'Single Gene Perturbations from GEO up' and 'Single Gene Perturbations from GEO down' categories were downloaded.

Statistical analysis {#Sec25}
--------------------

All the statistical analyses were conducted in the R software. HOSVD was carried out using the hosvd function in the rTensor package.

*In silico* evaluation of candidate drugs using SwissDock {#Sec26}
---------------------------------------------------------

SwissDock^[@CR47]^ was used for the *in silico* evaluation of binding affinity of the identified drugs for a prospective protein. For CYPOR, Protein Data Bank^[@CR48]^ (PDB) ID 1J9Z_A^[@CR49]^ was used to retrieve protein structure, and for HNF4A, PDB ID 4IQR_A^[@CR50]^ was used for this purpose. Compound structures provided by SwissDock when I searched by drug names, bezafibrate or morphine, were analysed. All the default options were chosen, and the binding structures associated with the smallest Δ*G* were selected.
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